Astillero, Margelyn P.

HRN: 23-79-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/13/2026
03/19/2026
IV
2.25
Q6
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  URTIReproductive TractProphylaxis    Compliance to guidelines: Compliant To Guidelines